Epithelialmesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Li, Y M ^a   Xu, S C ^a   Li, J ^a   Han, K Q ^a   Pi, H F ^a   Zheng, L ^a   Zuo, G H ^a   Huang, X B ^a   Li, H Y ^a   Zhao, H Z ^a   Yu, Z P ^a   Zhou, Z ^a   Liang, P ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Circulating tumor cells; Epithelialmesenchymal transition; Hepatocellular carcinoma; Metastasis

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ASIALOFETUIN; ASIALOGLYCOPROTEIN; FETUIN; TUMOR PROTEIN;

ADULT; ARTICLE; BLOOD; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CELL ISOLATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR THROMBUS; TUMOR VOLUME; WESTERN BLOTTING; BIOTINYLATION; CELL SEPARATION; DISEASE COURSE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STAINING; TUMOR CELL LINE; TUMOR EMBOLISM;

ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEINS; BIOTINYLATION; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SEPARATION; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FETUINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 84887490152     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.347     Document Type: Article

References (45)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576
2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491
3. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003; 21: 4329-4335
4. Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC et al. Epithelial-To-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 2010; 52: 945-953
5. Vogel I, Kalthoff H. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001; 439: 109-117
6. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448-456
7. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207
8. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011; 13: 228
9. Giesing M, Driesel G, Molitor D, Suchy B. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: Prediction of distant metastases. BJU Int 2012; 110 (11 Pt C): E1202-E1211
10. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer metastasis rev 2012; 31: 673-687
11. Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumor cells of early and metastatic breast cancer patients. Breast Cancer Res 2011; 13: R59
12. Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin Cancer Biol 2012; 22: 396-403
13. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939
14. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89
15. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-1618
16. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-2385
17. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278
18. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009; 50: 1464-1474
19. Zhou YM, Cao L, Li B, Zhang RX, Sui CJ, Yin ZF et al. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma. Ann Surg Oncol 2012; 19: 1700-1706
20. Swennenhuis JF, Tibbe AG, Levink R, Sipkema RC, Terstappen LW. Characterization of circulating tumor cells by fluorescence in situ hybridization. Cytometry 2009; 75: 520-527
21. Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 2011; 178: 989-996
22. Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial-mesenchymal transition: A hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 2012; 79: 195-208
23. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig 2009; 119: 1420-1428
24. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454
25. Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 2012; 14: R15
26. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 2011; 9: 997-1007
27. Wang S, Cheng L, Yu F, Pan W, Zhang J. Delivery of different length poly(L-lysine)-conjugated ODN to HepG2 cells using N- stearyllactobionamidemodified liposomes and their enhanced cellular biological effects. Int J Pharm 2006; 311: 82-88
28. Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S et al. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma. Int J Cancer 2012; 131: 2537-2546
29. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66: 8319-8326
30. Friedl P, Alexander S. Cancer invasion and the microenvironment: Plasticity and reciprocity. Cell 2011; 147: 992-1009
31. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27: 347-376
32. Gradilone A, Naso G, Raimondi C, Cortesi E, Gandini O, Vincenzi B et al. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): Prognosis, drug resistance and phenotypic characterization. Ann Oncol 2011; 22: 86-92
33. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y. Circulating tumor cells: Advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 2011; 137: 1151-1173
34. Mego M, Mani SA, Lee BN, Li C, Evans KW, Cohen EN et al. Expression of epithelialmesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy. Int J Cancer 2012; 130: 808-816
35. Konigsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F et al. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 2011; 50: 700-710
36. Severgnini M, Sherman J, Sehgal A, Jayaprakash NK, Aubin J, Wang G et al. A rapid twostep method for isolation of functional primary mouse hepatocytes: Cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology 2012; 64: 187-195
37. Xu W, Cao L, Chen L, Li J, Zhang XF, Qian HH et al. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy. Clin Cancer Res 2011; 17: 3783-3793
38. Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 2007; 120: 2650-2655
39. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43
40. Toyosaka A, Okamoto E, Mitsunobu M, Oriyama T, Nakao N, Miura K. Intrahepatic metastases in hepatocellular carcinoma: Evidence for spread via the portal vein as an efferent vessel. Am J Gastroenterol 1996; 91: 1610-1615
41. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503
42. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelialmesenchymal transition. Clin Cancer Res 2006; 12: 5369-5376
43. Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW, Che N et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry. Hepatology 2010; 51: 545-556
44. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011; 68: 3033-3046
45. Xu S, Pi H, Chen Y, Zhang N, Guo P, Lu Y et al. Cadmium induced Drp1-dependent mitochondrial fragmentation by disturbing calcium homeostasis in its hepatotoxicity. Cell Death Dis 2013; 4: E540